Northern Trust’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-70,837
| Closed | -$89K | – | 4870 |
|
|
2022
Q1 | $89K | Hold |
70,837
| – | – | ﹤0.01% | 4386 |
|
|
2021
Q4 | $82K | Buy |
70,837
+14,368
| +25% | +$21.4K | ﹤0.01% | 4478 |
|
|
2021
Q3 | $108K | Buy |
56,469
+16,587
| +42% | +$32.6K | ﹤0.01% | 4381 |
|
|
2021
Q2 | $93K | Hold |
39,882
| – | – | ﹤0.01% | 4382 |
|
|
2021
Q1 | $108K | Buy |
39,882
+200
| +0.5% | +$592 | ﹤0.01% | 4268 |
|
|
2020
Q4 | $96K | Buy |
39,682
+2,369
| +6% | +$5.4K | ﹤0.01% | 4122 |
|
|
2020
Q3 | $85K | Sell |
37,313
-6,326
| -14% | -$16.6K | ﹤0.01% | 4000 |
|
|
2020
Q2 | $100K | Buy |
43,639
+15,912
| +57% | +$36.6K | ﹤0.01% | 3922 |
|
|
2020
Q1 | $48K | Hold |
27,727
| – | – | ﹤0.01% | 3961 |
|
|
2019
Q4 | $57K | Hold |
27,727
| – | – | ﹤0.01% | 4036 |
|
|
2019
Q3 | $80K | Buy |
27,727
+11,011
| +66% | +$37.6K | ﹤0.01% | 3963 |
|
|
2019
Q2 | $66K | Buy |
16,716
+1
| +0% | +$5 | ﹤0.01% | 4037 |
|
|
2019
Q1 | $79K | Hold |
16,715
| – | – | ﹤0.01% | 3972 |
|
|
2018
Q4 | $38K | Hold |
16,715
| – | – | ﹤0.01% | 4095 |
|
|
2018
Q3 | $104K | Sell |
16,715
-8
| -0% | -$42 | ﹤0.01% | 4024 |
|
|
2018
Q2 | $114K | Sell |
16,723
-82,362
| -83% | -$616K | ﹤0.01% | 3989 |
|
|
2018
Q1 | $833K | Buy |
99,085
+61,620
| +164% | +$512K | ﹤0.01% | 3435 |
|
|
2017
Q4 | $348K | Sell |
37,465
-720
| -2% | -$7.24K | ﹤0.01% | 3641 |
|
|
2017
Q3 | $446K | Sell |
38,185
-140
| -0.4% | -$5.31K | ﹤0.01% | 3593 |
|
|
2017
Q2 | $1.6M | Buy |
38,325
+33,166
| +643% | +$1.6M | ﹤0.01% | 3294 |
|
|
2017
Q1 | $251K | Buy |
5,159
+749
| +17% | +$29.3K | ﹤0.01% | 3729 |
|
|
2016
Q4 | $145K | Buy |
4,410
+80
| +2% | +$2.63K | ﹤0.01% | 3826 |
|
|
2016
Q3 | $177K | Buy |
4,330
+846
| +24% | +$33.2K | ﹤0.01% | 3771 |
|
|
2016
Q2 | $114K | Sell |
3,484
-23,745
| -87% | -$870K | ﹤0.01% | 3864 |
|
|
2016
Q1 | $1.69M | Buy |
27,229
+80
| +0.3% | +$2.54K | ﹤0.01% | 3071 |
|
|
2015
Q4 | $1.15M | Buy |
27,149
+243
| +0.9% | +$11.6K | ﹤0.01% | 3277 |
|
|
2015
Q3 | $1.48M | Buy |
26,906
+17,910
| +199% | +$1.78M | ﹤0.01% | 3184 |
|
|
2015
Q2 | $988K | Buy |
8,996
+3,323
| +59% | +$309K | ﹤0.01% | 3349 |
|
|
2015
Q1 | $538K | Hold |
5,673
| – | – | ﹤0.01% | 3589 |
|
|
2014
Q4 | $318K | Sell |
5,673
-6
| -0.1% | -$410 | ﹤0.01% | 3684 |
|
|
2014
Q3 | $411K | Buy |
5,679
+203
| +4% | +$22.2K | ﹤0.01% | 3611 |
|
|
2014
Q2 | $822K | Buy |
5,476
+1,416
| +35% | +$215K | ﹤0.01% | 3473 |
|
|
2014
Q1 | $591K | Buy |
+4,060
| New | +$497K | ﹤0.01% | 3511 |
|
Other funds holding GNCA
Northern Trust's GNCA Position: Q2 2022 in Review
Northern Trust sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 70,837 shares — an estimated $89K sold.
Northern Trust first reported a position in GNCA in Q1 2014 and held it in 33 quarters. The position peaked at $1.69M in Q1 2016. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.
- Northern Trust reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
- Northern Trust sold 70,837 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $89K.
- Northern Trust first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 33 quarters.
- Northern Trust's Genocea Biosciences, Inc. position peaked at $1.69M in Q1 2016.
- 5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.
Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.